Vancomycin-Resistant Enterococcal Infections: Review of Eight Cases
Introduction: With the 1st reportof vancomycin-resistant Enterococcus (VRE) strains in 1988, nosocomial enterococcal infections and epidemics in units such as dialysis, transplantation and ICU started to be reported. Risk factors for VRE infection or colonization are underlying diseases, immunosuppr...
| Published in: | Mediterranean Journal of Infection, Microbes and Antimicrobials |
|---|---|
| Main Authors: | Fatma BAYRAK KENİ, Gönül ŞENGÖZ, Filiz PEHLİVANOĞLU |
| Format: | Article |
| Language: | English |
| Published: |
Infectious Diseases and Clinical Microbiology Specialty Society of Turkey
2014-12-01
|
| Subjects: | |
| Online Access: | http://www.mjima.org/pdf.php?&id=45 |
Similar Items
Emergence of multidrug resistance and extensive drug resistance among enterococcal clinical isolates in Egypt
by: Said HS, et al.
Published: (2019-05-01)
by: Said HS, et al.
Published: (2019-05-01)
Emergence of vancomycin-resistant enterococci in Switzerland: a nation-wide survey
by: Niccolò Buetti, et al.
Published: (2019-01-01)
by: Niccolò Buetti, et al.
Published: (2019-01-01)
Low prevalence of vancomycin resistant enterococci colonization in intensive care patients in a Brazilian teaching hospital
by: Antonia T. Tresoldi, et al.
by: Antonia T. Tresoldi, et al.
Antibiotic choices among healthcare professionals for enterococcal bacteremia with patterns of resistance and risk factors of mortality, in settings of poor antibiotic stewardship program — a five-year retrospective cohort study
by: Jamil Muqtadir Bhatti, et al.
Published: (2023-08-01)
by: Jamil Muqtadir Bhatti, et al.
Published: (2023-08-01)
Use of Linezolid in the treatment of surgical infectious complications under antibiotic resistance
by: O A Nazarchuk, et al.
Published: (2021-03-01)
by: O A Nazarchuk, et al.
Published: (2021-03-01)
Risk factors for mortality after linezolid treatment of vancomycin-resistant Enterococcus bloodstream infection
by: Szu-Ting Huang, et al.
Published: (2023-04-01)
by: Szu-Ting Huang, et al.
Published: (2023-04-01)
An Overview on Vancomycin Resistant Enterococcus faecalis
by: Kumurya, A.S., et al.
Published: (2021-06-01)
by: Kumurya, A.S., et al.
Published: (2021-06-01)
Prevalence of vancomycin resistance and multiple drug resistance in enterococci in equids in North India
by: Bhoj Raj Singh
Published: (2009-08-01)
by: Bhoj Raj Singh
Published: (2009-08-01)
Prevalence of Vancomycin-Resistant Enterococci and Antimicrobial Residues in Wastewater and Surface Water
by: Kristýna Hricová, et al.
Published: (2021-12-01)
by: Kristýna Hricová, et al.
Published: (2021-12-01)
Emergence of Vancomycin-Resistant Enterococci
by: Louis B. Rice
Published: (2001-04-01)
by: Louis B. Rice
Published: (2001-04-01)
Activity of vancomycin combined with linezolid against clinical vancomycin-resistant Enterococcus strains
by: Gulseren Aktas
Published: (2020-07-01)
by: Gulseren Aktas
Published: (2020-07-01)
Vancomycin-resistant Enterococci, Mexico City
by: Jennifer Cuellar-Rodríguez, et al.
Published: (2007-05-01)
by: Jennifer Cuellar-Rodríguez, et al.
Published: (2007-05-01)
Linezolid and vancomycin for nosocomial infections in pediatric patients: a systematic review
by: Bruno Russo Porchera, et al.
Published: (2024-05-01)
by: Bruno Russo Porchera, et al.
Published: (2024-05-01)
Molecular Epidemiology of Vancomycin-Resistant Enterococci Bloodstream Infections in Germany: A Population-Based Prospective Longitudinal Study
by: Carlos L. Correa-Martínez, et al.
Published: (2022-01-01)
by: Carlos L. Correa-Martínez, et al.
Published: (2022-01-01)
Gut colonization with vancomycin-resistant Enterococcus and risk for subsequent enteric infection
by: Jordan E. Axelrad, et al.
Published: (2018-07-01)
by: Jordan E. Axelrad, et al.
Published: (2018-07-01)
The ongoing challenge of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Europe: an epidemiological analysis of bloodstream infections
by: Olaniyi Ayobami, et al.
Published: (2020-01-01)
by: Olaniyi Ayobami, et al.
Published: (2020-01-01)
In vitro and in vivo activities of the carbonic anhydrase inhibitor, dorzolamide, against vancomycin-resistant enterococci
by: Nader S. Abutaleb, et al.
Published: (2021-03-01)
by: Nader S. Abutaleb, et al.
Published: (2021-03-01)
Pharmacodynamics Of Linezolid-Plus-Fosfomycin Against Vancomycin-Susceptible And -Resistant Enterococci In Vitro And In Vivo Of A Galleria mellonella Larval Infection Model
by: Qi C, et al.
Published: (2019-11-01)
by: Qi C, et al.
Published: (2019-11-01)
Clinical profile and antibiotic susceptibility pattern of Enterococcus faecalis and Enterococcus faecium with an emphasis on vancomycin resistance
by: Mohan Bilikallahalli Sannathimmappa, et al.
Published: (2023-01-01)
by: Mohan Bilikallahalli Sannathimmappa, et al.
Published: (2023-01-01)
Combined Action of Antibiotics and Bacteriocins against Vancomycin-Resistant Enterococci
by: Jorge Enrique Vazquez Bucheli, et al.
Published: (2022-07-01)
by: Jorge Enrique Vazquez Bucheli, et al.
Published: (2022-07-01)
Nosocomial Infection with Vancomycin-dependent Enterococci
by: Paul A. Tambyah, et al.
Published: (2004-07-01)
by: Paul A. Tambyah, et al.
Published: (2004-07-01)
Fecal Colonization with Vancomycin-Resistant Enterococci in Australia
by: Alexander A. Padiglione, et al.
Published: (2000-10-01)
by: Alexander A. Padiglione, et al.
Published: (2000-10-01)
Cytotoxic Activity of Vancomycin-Resistant Enterococci Isolated from Hospitalised Patients
by: Ewa Szczuka, et al.
Published: (2024-09-01)
by: Ewa Szczuka, et al.
Published: (2024-09-01)
Vancomycin resistant enterococcus bacteremia in a patient with pneumocystis jiroveci pneumonia, granulocystic sarcoma and acute respiratory distress syndrome
by: Julide Celdir Emre, et al.
Published: (2014-01-01)
by: Julide Celdir Emre, et al.
Published: (2014-01-01)
THE EFFECT OF LINEZOLID AGAINST VANCOMYCIN-RESISTANT ENTEROCOCCI BY VARIOUS METHODS
by: Başak Sıla Eyüp, et al.
Published: (2024-02-01)
by: Başak Sıla Eyüp, et al.
Published: (2024-02-01)
The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections
by: Tobias Siegfried Kramer, et al.
Published: (2018-11-01)
by: Tobias Siegfried Kramer, et al.
Published: (2018-11-01)
Vancomycin-resistant enterococci (VRE) screening and isolation in the general medicine ward: a cost-effectiveness analysis
by: Stephen Mac, et al.
Published: (2019-10-01)
by: Stephen Mac, et al.
Published: (2019-10-01)
Risk Factors for Long-Term Vancomycin-Resistant Enterococci Persistence—A Prospective Longitudinal Study
by: Carlos L. Correa-Martinez, et al.
Published: (2019-09-01)
by: Carlos L. Correa-Martinez, et al.
Published: (2019-09-01)
Clinical Considerations in the Approach to Vancomycin-Resistant Enterococci: A Narrative Review
by: John W. Beale, et al.
Published: (2022-06-01)
by: John W. Beale, et al.
Published: (2022-06-01)
Comparison of morbidity and mortality after bloodstream infection with vancomycin-resistant versus -susceptible Enterococcus faecium: a nationwide cohort study in Denmark, 2010–2019
by: Peter Bager, et al.
Published: (2024-12-01)
by: Peter Bager, et al.
Published: (2024-12-01)
Epidemiology of vancomycin-resistant enterococci in the United Arab Emirates: a retrospective analysis of 12 years of national AMR surveillance data
by: Jens Thomsen, et al.
Published: (2023-11-01)
by: Jens Thomsen, et al.
Published: (2023-11-01)
Management of a hospital-wide vancomycin-resistant Enterococcus faecium outbreak in a Dutch general hospital, 2014–2017: successful control using a restrictive screening strategy
by: Veronica Weterings, et al.
Published: (2021-02-01)
by: Veronica Weterings, et al.
Published: (2021-02-01)
Vancomycin-Resistant Enterococci: Screening Efficacy and the Risk of Bloodstream Infections in a Specialized Healthcare Setting
by: Assunta Navarra, et al.
Published: (2025-03-01)
by: Assunta Navarra, et al.
Published: (2025-03-01)
Rapid Transmission and Divergence of Vancomycin-Resistant Enterococcus faecium Sequence Type 80, China
by: Liqiang Li, et al.
Published: (2025-05-01)
by: Liqiang Li, et al.
Published: (2025-05-01)
Gallbladder Cancer Presenting as Mirizzi Syndrome Complicated by Rapidly Evolving 23 rRNA Gene-Linezolid Resistance with Vancomycin-Resistant Enterococcus Infection Resulting in Fatal Cholangial Sepsis
by: Daniel Schmitz, et al.
Published: (2020-10-01)
by: Daniel Schmitz, et al.
Published: (2020-10-01)
Novel Multidrug-Resistant Enterococcal Mobile Linear Plasmid pELF1 Encoding vanA and vanM Gene Clusters From a Japanese Vancomycin-Resistant Enterococci Isolate
by: Yusuke Hashimoto, et al.
Published: (2019-11-01)
by: Yusuke Hashimoto, et al.
Published: (2019-11-01)
Our experiences with vancomycin-resistant enterococci in Jesenice General hospital
by: Helena Ribič, et al.
Published: (2007-11-01)
by: Helena Ribič, et al.
Published: (2007-11-01)
High-level aminoglycoside resistance and reduced susceptibility to vancomycin in nosocomial enterococci
by: Luna Adhikari
Published: (2010-01-01)
by: Luna Adhikari
Published: (2010-01-01)
Vancomycin-resistant van a phenotype Enterococcus faecalis: first case in Minas Gerais state and epidemiological considerations
by: Rosineide Marques Ribas, et al.
by: Rosineide Marques Ribas, et al.
Epidemiology of invasive infections caused by vancomycin sensitive and resistant enterococcal strains among oncology patients at the National Cancer Institute of Sri Lanka from 1st of July 2012 to 31st of July 2013
by: LS Athukorala, et al.
Published: (2018-10-01)
by: LS Athukorala, et al.
Published: (2018-10-01)
Similar Items
-
Emergence of multidrug resistance and extensive drug resistance among enterococcal clinical isolates in Egypt
by: Said HS, et al.
Published: (2019-05-01) -
Emergence of vancomycin-resistant enterococci in Switzerland: a nation-wide survey
by: Niccolò Buetti, et al.
Published: (2019-01-01) -
Low prevalence of vancomycin resistant enterococci colonization in intensive care patients in a Brazilian teaching hospital
by: Antonia T. Tresoldi, et al. -
Antibiotic choices among healthcare professionals for enterococcal bacteremia with patterns of resistance and risk factors of mortality, in settings of poor antibiotic stewardship program — a five-year retrospective cohort study
by: Jamil Muqtadir Bhatti, et al.
Published: (2023-08-01) -
Use of Linezolid in the treatment of surgical infectious complications under antibiotic resistance
by: O A Nazarchuk, et al.
Published: (2021-03-01)
